44 related articles for article (PubMed ID: 8057661)
1. Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.
Salzer WL; Jones TL; Devidas M; Dreyer ZE; Gore L; Winick NJ; Sung L; Raetz E; Loh ML; Wang CY; De Lorenzo P; Valsecchi MG; Pieters R; Carroll WL; Hunger SP; Hilden JM; Brown P
Pediatr Blood Cancer; 2015 Mar; 62(3):414-8. PubMed ID: 25407157
[TBL] [Abstract][Full Text] [Related]
2. Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
Dreyer ZE; Hilden JM; Jones TL; Devidas M; Winick NJ; Willman CL; Harvey RC; Chen IM; Behm FG; Pullen J; Wood BL; Carroll AJ; Heerema NA; Felix CA; Robinson B; Reaman GH; Salzer WL; Hunger SP; Carroll WL; Camitta BM
Pediatr Blood Cancer; 2015 Mar; 62(3):419-26. PubMed ID: 25399948
[TBL] [Abstract][Full Text] [Related]
3. The evolution of clinical trials for infant acute lymphoblastic leukemia.
Kotecha RS; Gottardo NG; Kees UR; Cole CH
Blood Cancer J; 2014 Apr; 4(4):e200. PubMed ID: 24727996
[TBL] [Abstract][Full Text] [Related]
4. Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.
Salzer WL; Jones TL; Devidas M; Hilden JM; Winick N; Hunger S; Carroll WL; Camitta B; Dreyer ZE
Pediatr Blood Cancer; 2012 Nov; 59(5):834-9. PubMed ID: 22488662
[TBL] [Abstract][Full Text] [Related]
5. Infant acute lymphoblastic leukemia: Lessons learned and future directions.
Pieters R
Curr Hematol Malig Rep; 2009 Jul; 4(3):167-74. PubMed ID: 20425430
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report.
Satwani P; Sather H; Ozkaynak F; Heerema NA; Schultz KR; Sanders J; Kersey J; Davenport V; Trigg M; Cairo MS
Biol Blood Marrow Transplant; 2007 Feb; 13(2):218-27. PubMed ID: 17241927
[TBL] [Abstract][Full Text] [Related]
7. Successful outcome of mismatched hematopoietic stem cell transplantation from a related donor in an infant with acute lymphoblastic leukemia and 9;11 translocation: case report and review of the literature.
Kitazawa J; Tono C; Terui K; Kinukawa N; Oda M; Isoyama K; Ishii E; Ito E;
Int J Hematol; 2005 Jun; 81(5):428-32. PubMed ID: 16158826
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
Sanders JE; Im HJ; Hoffmeister PA; Gooley TA; Woolfrey AE; Carpenter PA; Andrews RG; Bryant EM; Appelbaum FR
Blood; 2005 May; 105(9):3749-56. PubMed ID: 15637143
[TBL] [Abstract][Full Text] [Related]
9. Acute lymphoblastic leukemia: optimizing treatment strategies in children.
Vora A
Paediatr Drugs; 2002; 4(6):405-16. PubMed ID: 12038876
[TBL] [Abstract][Full Text] [Related]
10. Leukemia in infants.
Somjee S; Sapre R; Shinde S; Kumar A; Dhond S; Badrinath Y; Mahadik S; Chougale A; Ansari R; Nair CN; Advani SH
Indian J Pediatr; 2002 Mar; 69(3):225-7. PubMed ID: 12003297
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system-directed therapy in the treatment of childhood acute lymphoblastic leukemia and studies of neurobehavioral outcome: Children's Cancer Group trials.
Kaleita TA
Curr Oncol Rep; 2002 Mar; 4(2):131-41. PubMed ID: 11822985
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic trials in childhood ALL: what's their future?
Eden OB
J Clin Pathol; 2000 Jan; 53(1):55-9. PubMed ID: 10767858
[No Abstract] [Full Text] [Related]
13. Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994.
Stiller CA; Eatock EM
Arch Dis Child; 1999 Sep; 81(3):202-8. PubMed ID: 10451391
[TBL] [Abstract][Full Text] [Related]
14. Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parents.
Rinaldi F; Mairs RJ; Wheldon TE; Katz F; Chessells JM; Gibson BE
Br J Cancer; 1999 May; 80(5-6):909-13. PubMed ID: 10360674
[TBL] [Abstract][Full Text] [Related]
15. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
Chessells JM; Eden OB; Bailey CC; Lilleyman JS; Richards SM
Leukemia; 1994 Aug; 8(8):1275-9. PubMed ID: 8057661
[TBL] [Abstract][Full Text] [Related]
17. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
[TBL] [Abstract][Full Text] [Related]
18. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
Chessells JM; Bailey C; Richards SM
Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.
Gibson BE; Wheatley K; Hann IM; Stevens RF; Webb D; Hills RK; De Graaf SS; Harrison CJ
Leukemia; 2005 Dec; 19(12):2130-8. PubMed ID: 16304572
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
